Health

How to Get Your Partner to Stop Snoring

A good night's sleep is still possible if you guide your bedmate toward these sn...

The EPA Banned a Pesticide That Is Dangerous for Fetuse...

The pesticide, dimethyl tetrachloroterephthalate, is used to control weeds on cr...

Do You Really Store Stress in Your Body?

Stress doesn't just live in your belly or lower back.

IVF Changed America. But Its Future Is Under Threat

It may be the next battle in the reproductive-rights war.

Do You Really Need a Water Filter?

Will a simple pitcher do, or should you revamp your home's entire water filtrati...

There Are No Good Treatments for PTSD. MDMA Can Change ...

Christiana Musk needed MDMA-assisted therapy 20 years ago. Other women with PTSD...

Products Can Harm People for Decades Before Companies C...

So-called "market-driven epidemics" underlie urgent health crises, write Jonatha...

Making Sense of the Connection Between Vaccines and Lup...

What to know before a vaccine meets a disordered immune system.

Cigna explores shedding Medicare Advantage business 

Reuters was first to report that U.S. health insurer Cigna Group (CI.N) is explo...

Lilly to build $2.5 billion Germany plant as obesity dr...

Reuters exclusively reported that Eli Lilly (LLY.N) will build its first plant i...

Bayer’s new CEO plans to cut management jobs in prelude...

Reuters exclusively reported that Bayer’s (BAYGn.DE) new CEO plans to cut manage...

US FDA finds control lapses at Moderna manufacturing pl...

Reuters exclusively reported that U.S. drug regulators in September found qualit...

Edwards Lifesciences cooperating with EU antitrust regu...

Reuters exclusively reported that US medical device maker Edwards Lifesciences, ...

Eli Lilly could launch obesity drug in India next year

Reuters exclusively reported that U.S. drugmaker Eli Lilly LLY.N expects to laun...

Major Bayer shareholder Harris backs CEO’s focus on int...

Reuters exclusively reported that major Bayer shareholder Harris Associates came...

Novo Nordisk says experimental drug amycretin show 13% ...

Reuters was first to report on the early trial data for Novo Nordisk’s highly an...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.